Send your comments and tips to firstname.lastname@example.org
Beth Israel Deaconess Medical Ctr.
Boston Medical Center
Brigham and Women's Hospital
Cambridge Health Alliance
Caritas St. Elizabeth's Medical Ctr.
Children's Hospital Boston
Dana-Farber Cancer Institute
Joslin Diabetes Center
Mass. General Hospital
Mass. Health Law
New England Baptist Hospital
Short White Coat
Tufts-New England Medical Center
UMass Memorial Medical Center
University of Massachusetts
VA Medical Centers
A Healthy Blog
Running A Hospital
Nature Network Boston
SciBos - Corie Lok's blog
Dr. Flea's blog
Nurse at small
Your Child's Health Blog
Healthy Children blog
Other Globe Blogs
Elizabeth Cooney is a health reporter for the Worcester Telegram & Gazette.
Boston Globe Health and Science staff:
Karen Weintraub, Deputy Health and Science Editor, and Gideon Gil, Health and Science Editor.
Short White Coat blogger Ishani Ganguli
Monday, February 19, 2007
Today's Globe: Child psychiatrist in spotlight, concussions, alternative medicine books, blind children in India, Crohn's treatments
The death of a 4-year-old Hull girl has put Dr. Kayoko Kifuji, a Tufts-New England Medical Center psychiatrist who treated the girl, at the center of controversy.
The repeat concussions suffered by former New England Patriots linebacker Ted Johnson have brought new attention to concussions in sports. Writer Joseph Williams, himself a former football player, writes that the culture of athletics and human nature are the largest hurdles to preventing head injuries.
Also in today's Health/Science section: Columnist Judy Foreman recommends her favorite books about alternative medicine; MIT neuroscientist Pawan Sinha says his research on congenital cataracts in India suggests that sight can be restored in older children thought permanently blind; and a profile of Dr. Paul K. Kleinman, a Children's Hospital Boston pediatric radiologist who had done pioneering work on identifying victims of child abuse.
In Business & Innovation: two treatments for Crohn's disease are expected to get FDA approval this year.